BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29571968)

  • 1. Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - A personal view.
    Damato B
    Prog Retin Eye Res; 2018 Sep; 66():187-199. PubMed ID: 29571968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
    Bourla DH; Young TA
    Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
    van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
    Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late results in treating uveal melanomas. A comparative evaluation of enucleation and organ-preserving treatment methods].
    Libman ES; Brovkina AF; Bezrukov AV
    Oftalmol Zh; 1989; (6):336-8. PubMed ID: 2622596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does ocular treatment of uveal melanoma influence survival?
    Damato B
    Br J Cancer; 2010 Jul; 103(3):285-90. PubMed ID: 20661247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival.
    Damato BE; Heimann H; Kalirai H; Coupland SE
    JAMA Ophthalmol; 2014 May; 132(5):605-13. PubMed ID: 24626610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Course of a Presumed Metastatic Uveal Melanoma to the Contralateral Choroid.
    Caminal Mitjana JM; Vilà Grané N; Adán Civera A; Sabater N; Arias Barquet L; Rubio Caso MJ
    Semin Ophthalmol; 2015; 30(5-6):417-9. PubMed ID: 24171794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
    Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
    JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic disease in uveal melanoma: importance of a genetic profile?
    Van Beek JG; Koopmans AE; Vaarwater J; Verdijk RM; de Klein A; Naus NC; Kiliç E
    Melanoma Res; 2015 Oct; 25(5):447-9. PubMed ID: 26086698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GROWTH OF PRESUMED CHOROIDAL NEVUS INTO MELANOMA OVER 4 YEARS IN BAP1 TUMOR PREDISPOSITION SYNDROME.
    Masoomian B; Shields CL; Mashayekhi A; Ganguly A; Shields JA
    Retin Cases Brief Rep; 2021 Mar; 15(2):93-96. PubMed ID: 29994997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal melanoma: physiopathology and new in situ-specific therapies.
    Souto EB; Zielinska A; Luis M; Carbone C; Martins-Gomes C; Souto SB; Silva AM
    Cancer Chemother Pharmacol; 2019 Jul; 84(1):15-32. PubMed ID: 31079217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveal melanoma: relatively rare but deadly cancer.
    Kaliki S; Shields CL
    Eye (Lond); 2017 Feb; 31(2):241-257. PubMed ID: 27911450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral uveal melanomas with different gene expression detected with 7 years interval.
    Eide N; Garred Ø; Beiske K; Fodstad Ø
    Acta Ophthalmol; 2016 Feb; 94(1):99-102. PubMed ID: 26496992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of posterior uveal melanoma.
    Shields JA; Shields CL
    Mayo Clin Proc; 1993 Dec; 68(12):1196-200. PubMed ID: 8246622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
    van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
    Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of intraocular melanoma: new concepts].
    De Potter P
    Bull Mem Acad R Med Belg; 2003; 158(1-2):103-11; discussion 111-2. PubMed ID: 12852096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.